Is symptom-oriented follow-up still up to date?

Area of Science:

• Oncology
• Medical Follow-up Protocols
• Breast Cancer Management

Background:

• Post-primary treatment breast cancer follow-up aims to detect curable events like local recurrences and contralateral breast cancer.
• Patient counseling on therapies, psychosocial aspects, side effects, and lifestyle interventions is crucial for enhancing quality of life.
• The benefit of early detection of asymptomatic metastasis remains under discussion, with current follow-up being symptom-oriented.

Purpose of the Study:

• To outline current best practices for breast cancer patient follow-up.
• To evaluate the efficacy of intensified screening versus symptom-oriented follow-up.
• To discuss future directions in personalized follow-up strategies for breast cancer.

Main Methods:

• Review of current follow-up guidelines and literature.
• Analysis of the benefits and limitations of intensified screening protocols.
• Consideration of emerging therapies for metastatic breast cancer and their impact on follow-up.

Main Results:

• Intensified imaging and laboratory check-ups have not demonstrated improved survival benefits for patients.
• Recommended follow-up intervals are every 3 months for the first 2-3 years, then every 6 months.
• Routine diagnostic imaging, excluding mammography/ultrasound, is not indicated for asymptomatic patients.

Conclusions:

• Current follow-up strategies focus on symptom detection and regular consultations, physical examinations, and mammography/ultrasound.
• While innovative therapies are emerging, individualized follow-up programs for early metastasis detection are not yet supported by robust data.
• Future follow-up may incorporate novel therapies and personalized approaches, potentially improving survival in early-detected metastasis.